ADPT logo

ADPT
Adaptive Biotechnologies Corp

4,296
Mkt Cap
$2.23B
Volume
1.59M
52W High
$20.76
52W Low
$6.77
PE Ratio
-36.29
ADPT Fundamentals
Price
$14.47
Prev Close
$14.08
Open
$14.55
50D MA
$14.69
Beta
1.74
Avg. Volume
2.34M
EPS (Annual)
-$0.3922
P/B
10.17
Rev/Employee
$443,871.79
$2,453.55
Loading...
Loading...
News
all
press releases
Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares?
Key Points57,180 shares were sold for a total transaction value of approximately ~$826,000 across multiple days ending April 16, 2026...
Nasdaq News: Markets·1d ago
News Placeholder
More News
News Placeholder
Adaptive Biotechnologies Corporation $ADPT Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. reduced its position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 46.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,947,963 shares of the company's stock after selling 1,702,683 shares during t...
MarketBeat·2d ago
News Placeholder
Adaptive Biotechnologies Corporation $ADPT Shares Sold by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA lessened its stake in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 25.6% during the 4th quarter, according to its most recent 13F filing...
MarketBeat·2d ago
News Placeholder
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 19,060 Shares of Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the stock in a transaction dated Thursday, April 16th. The stock was sold at an average...
MarketBeat·3d ago
News Placeholder
Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $250,639.00 in Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the company's stock in a transaction on Monday, April 13th. The shares were sold at an...
MarketBeat·6d ago
News Placeholder
Julie Rubinstein Sells 19,060 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the company's stock in a transaction that occurred on Friday, April 10th. The shares...
MarketBeat·6d ago
News Placeholder
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Up 8.2% - Here's What Happened
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 8.2% - Should You Buy...
MarketBeat·6d ago
News Placeholder
Harlan Robins Sells 10,000 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Harlan Robins sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $14.85, for a total transaction of $148,500.00. Following the...
MarketBeat·8d ago
News Placeholder
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $148,500.00 in Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Harlan Robins sold 10,000 shares of Adaptive Biotechnologies stock in a transaction that occurred on Wednesday, April 8th...
MarketBeat·9d ago
News Placeholder
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Francis Lo Sells 22,564 Shares
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Francis Lo sold 22,564 shares of the firm's stock in a transaction on Wednesday, April 8th. The shares were sold at an...
MarketBeat·9d ago
<
1
2
...
>

Latest ADPT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.